Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY: PFE )

22.39 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Apr 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 22.39
Bid (Size) 22.40 (40)
Ask (Size) 22.44 (16)
Prev. Close 22.39
Today's Range 22.39 - 22.39
52wk Range 20.91 - 31.54
Shares Outstanding 5,606,688,356
Dividend Yield 7.68%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Summit Therapeutics Retail Traders Stoked As Stock Surges On Promising Cancer Drug Trial
The study was conducted across multiple centers in China, comparing ivonescimab plus chemotherapy against tislelizumab (marketed as Tevimbra by BeiGene) plus chemotherapy. 
Via Stocktwits
Novavax's COVID-19 Vaccine Nears FDA Full Approval, Stock Jumps
Novavax's COVID-19 vaccine showed fewer side effects than Pfizer's in a Utah study as FDA seeks more data before full approval decision. 
Via Benzinga
Exposures COVID-19 Product Safety

Performance

YTD
-15.86%
-15.86%
1 Month
-14.35%
-14.35%
3 Month
-13.92%
-13.92%
6 Month
-22.42%
-22.42%
1 Year
-14.93%
-14.93%

More News

Read More
Pfizer Declares Second-Quarter 2025 Dividend
From Pfizer Inc.
Via Business Wire
Looking for the most active stocks in the S&P500 index on Wednesday?
Via Chartmill
Why Is Summit Therapeutics Stock Soaring On Wednesday?
Via Benzinga
Pfizer Advances Bold Vision for Future of Cancer Care at the ASCO 2025 Annual Meeting
From Pfizer Inc.
Via Business Wire
Novavax Signals Chances Of FDA Approval For Its COVID-19 Vaccine: But Retail Sentiment Wavers
Via Stocktwits
Topics Government
Exposures COVID-19 Political Product Safety
3 of Wall Street’s Favorite Stocks Walking a Fine Line
Via StockStory
2 High-Yield Dividend Stocks to Buy for Passive Income
Via The Motley Fool
Topics Retirement
Exposures COVID-19 Pension
Trump Administration Considers Lowering US Drug Prices To International Levels: Report
Via Benzinga
Topics Government
Exposures Political
What's Next for Pfizer After the Company Pulls Its Weight Loss Drug?
Via The Motley Fool
Is Eli Lilly Stock a Buy?
Via The Motley Fool
S&P 500 Sell-Off: 2 Ultra-High-Yield Dividend Stocks That Make for No-Brainer Buys
Via The Motley Fool
Topics Stocks
Exposures US Equities
Why Vertex Pharmaceuticals Was Such a Healthy Stock on Tuesday
Via The Motley Fool
Forecasting The Future: 6 Analyst Projections For Pfizer
Via Benzinga
Upcoming Pfizer Earnings Call Might Be Focused On Tariffs, Policy Risks And Obesity Pipeline
Via Benzinga
Topics Earnings
Exposures Financial
How To Put $100 In Your Retirement Fund Each Month With Pfizer Stock
Via Benzinga
Topics Retirement
Exposures Pension
Hertz Global And Webull Stocks Are Among Top Mid-Cap Gainers Last Week (Apr 14-Apr 18): Are The Others In Your Portfolio?
Via Benzinga
3 Ultra-High-Yield Dividend Stocks to Buy Right Now That Are Dirt Cheap
Via The Motley Fool
Topics Economy Energy
Exposures Climate Economy Fossil Fuels
A Once-in-a-Decade Opportunity: 3 Magnificent Stocks Down Between 40% and 73% to Buy Right Now
Via The Motley Fool
3 Magnificent Stocks to Buy That Are Near 52-Week Lows
Via The Motley Fool
Topics Economy Government
Exposures COVID-19 Economy Political
Pfizer Abandons Its Leading Weight Loss Candidate. Should You Sell the Stock?
Via The Motley Fool
Where Will Eli Lilly Be in 5 Years?
Via The Motley Fool
3 Magnificent S&P 500 Dividend Stocks Down 11% to 63% to Buy and Hold Forever
Via The Motley Fool
Topics Stocks
Exposures US Equities
Thursday's session: most active stock in the S&P500 index
Via Chartmill
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.